Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033036 (
APC
)
10,214
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
PKHD1
(polycystic kidney and hepatic disease 1) gene responsible for autosomal recessive polycystic kidney disease has been mapped to 6p21.1-p12 to an approximately 1-cM interval flanked by the markers D6S1714/D6S243 and D6S1024. We have developed a sequence-ready BAC/
PAC
-based contig map of this region as the next step for the positional cloning of
PKHD1
. This contig comprising 52 clones spanning approximately 1 Mb was established by content mapping of 44 BAC/
PAC
-end-derived STSs, 3 known genetic markers, 5 YAC-end-derived STSs, 3 random STSs, 1 previously mapped gene, and 1 EST. The average depth per marker is 6.3 clones, and the average STS density is 20 kb. The genomic clone overlaps were confirmed by restriction fragment fingerprint analysis. A high-resolution BAC/
PAC
-based contig map is essential to the ultimate goal of identifying the
PKHD1
gene.
...
PMID:A 1-Mb BAC/PAC-based physical map of the autosomal recessive polycystic kidney disease gene (PKHD1) region on chromosome 6. 1019 64
Autosomal recessive polycystic kidney disease
(
ARPKD
) is an often devastating form of polycystic kidney disease that presents primarily in infancy. The locus,
PKHD1
(polycystic kidney and hepatic disease 1), on chromosome 6p21.1-p12, has been linked to all classical forms of this disorder. In previous studies, we cloned the
PKHD1
interval in a set of overlapping YACs, converted this YAC-based framework into a BAC/
PAC
contig, and delimited the critical interval to a region flanked by the markers D6S1714 and D6S1024. We now have refined the genetic interval using new polymorphic markers developed from our BAC/
PAC
resources. In addition, we have evaluated a recently identified, EF hand-containing gene that maps to the interval of interest, established its transcript sequence, defined its genomic organization, and excluded this new gene as a
PKHD1
candidate. Therefore, this study has narrowed the
PKHD1
interval and excluded a potentially relevant gene as a
PKHD1
candidate gene. This further refinement of the
PKHD1
interval will facilitate efforts to identify the
PKHD1
gene by positional cloning. These data also provide additional, highly polymorphic markers for haplotype-based diagnostic testing for
ARPKD
.
...
PMID:Refinement of the autosomal recessive polycystic kidney disease (PKHD1) interval and exclusion of an EF hand-containing gene as a PKHD1 candidate gene. 1211 8